MCM
GSK icon

Maryland Capital Management’s GSK GSK Stock Holding History

Maryland Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,379
Closed -$226K – 183
2013
Q4 		$226K Buy
3,379
+40
+1% +$2.59K 0.04% 190
2013
Q3 		$209K Sell
3,339
-400
-11% -$25.7K 0.03% 207
2013
Q2 		$234K Buy
+3,739
New +$237K 0.04% 188

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maryland Capital Management's GSK Position: Q1 2014 in Review

Maryland Capital Management sold out of GSK (GSK) in Q1 2014, closing a stake of 3,379 shares — an estimated $226K sold.

Maryland Capital Management first reported a position in GSK in Q2 2013 and held it in 3 quarters. The position peaked at $234K in Q2 2013. 712 funds tracked by Wall St. Rank hold GSK as of Q1 2014.

  • Maryland Capital Management reported no remaining GSK position as of Q1 2014 after selling out during the quarter.
  • Maryland Capital Management sold 3,379 GSK shares in Q1 2014, an estimated $226K.
  • Maryland Capital Management first reported a position in GSK in Q2 2013 and held it in 3 quarters.
  • Maryland Capital Management's GSK position peaked at $234K in Q2 2013.
  • 712 funds tracked by Wall St. Rank held GSK as of Q1 2014.

Based on Maryland Capital Management's 13F filing for Q1 2014, filed 15 May 2014.